Cargando…
Pathogenic epitopes, heterologous immunity and vaccine design
Substantial research has been directed towards the development of a new generation of vaccines that are based on the inclusion of immunogenic epitopes in recombinant vectors. Here we examine the evidence that under certain conditions immunogenic epitopes can do more harm than good and might therefor...
Autores principales: | Welsh, Raymond M., Fujinami, Robert S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097378/ https://www.ncbi.nlm.nih.gov/pubmed/17558423 http://dx.doi.org/10.1038/nrmicro1709 |
Ejemplares similares
-
Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations
por: Selin, Liisa K., et al.
Publicado: (1998) -
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
por: Fleri, Ward, et al.
Publicado: (2017) -
CD8 memory T cells: cross-reactivity and heterologous immunity
por: Selin, Liisa K., et al.
Publicado: (2004) -
Loss of Anti-Viral Immunity by Infection with a Virus Encoding a Cross-Reactive Pathogenic Epitope
por: Chen, Alex T., et al.
Publicado: (2012) -
Private specificities of CD8 T cell responses control patterns of heterologous immunity
por: Kim, Sung-Kwon, et al.
Publicado: (2005)